Neej Patel, MD
Gastroenterology · New Orleans, LANPI 1861871212
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,070 of the $3,383 with a category attached, or 61.2%. Boston Scientific accounts for 85.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $1,288 and has fallen 73.2% since, to $345 in 2025. That places this record below the midpoint for gastroenterology clinicians in LA, where the typical reported total is $3,631.
Across 29 payments — averaging $116.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- ERBE USA Inc$270
- Gilead$124
- Olympus Corporation Of The Americas$71
- Cook Medical LLC$24
- AbbVie$14
What the payments were for
- Travel & lodging$2,07061%
- Food & beverage$1,31339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $2,879 |
| ERBE USA Inc | 2 | $270 |
| Gilead | 1 | $124 |
| Olympus Corporation Of The Americas | 2 | $71 |
| Cook Medical LLC | 1 | $24 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$2,020
- EXALT Model D$362
- Erbe VIO3$270
How this compares
$3,383 in reported general payments places this provider in the 45th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 147 | $2,961 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 29 | $2,073 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 61 | $1,229 |
| Sucralfate | 11 | $1,039 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $379 |
| Ciprofloxacin Hcl | 110 | $363 |
| Esomeprazole Magnesium | 11 | $248 |
| Omeprazole | 16 | $192 |
| Fluconazole | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New Orleans
- Sarah GloverNew Orleans$274K
- Nisha LoganantharajNew Orleans$173K
- Shamita ShahNew Orleans$114K
- Vivek HuilgolNew Orleans$37K
- Arnab RayNew Orleans$26K
- Janak ShahNew Orleans$18K
- Stephen LandreneauNew Orleans$17K
- Virendra JoshiNew Orleans$16K
- Parth ParekhNew Orleans$10K
- Jonathon ChapmanBaton Rouge$998K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.